The Life Sciences Practice works with innovators at the earliest stages of research and development. We regularly work with an innovator's CROs that can provide additional experimental and analytical work to further develop the technology. The information and data generated by the CRO can then be incorporated into an intellectual property strategy to bolster the value of the underlying intellectual property, provide proof of concept to anticipate investors' due diligence, and begin the pre-clinical trial or drug application process.

An innovator's investors and potential investors can provide market and competitive intelligence information that may assist in targeting patent claims to certain industry sectors. For example, if a technology is useful in several industrial sectors, but one of the sectors is perceived to be under-invested, then an intellectual property strategy can be developed to highlight the use in that under-invested sector.

Working with marketing strategists can clarify market uncertainties to enhance the return on investment in protecting intellectual property. For example, if it is discovered that certain countries are reluctant to adopt an innovative technology, an intellectual property strategy can be developed to highlight potential alternative uses of the technology in those countries.

Finally, if your intellectual property strategy requires vigorous enforcement of your rights in a court system, Spencer Fane provides a strong track records of litigation success in protecting innovative technologies.